logo
Plus   Neg
Share
Email

Seagen: CHMP Adopts Positive Opinion For TUKYSA - Quick Facts

Biotechnology company Seagen Inc. (SGEN) said Friday that the Committee for Medicinal Products for Human Use or CHMP of the European Medicines Agency has adopted a positive opinion for TUKYSA (tucatinib) for the treatment of patients with locally advanced or metastatic HER2-Positive breast cancer.

The CHMP positive opinion recommends the approval of TUKYSA in combination with trastuzumab and capecitabine for the treatment of adult patients with HER2-positive locally advanced or metastatic breast cancer who have received at least 2 prior anti-HER2 treatment regimens.

The CHMP positive opinion will now be considered by the European Commission or EC, which has the authority to approve medicines in the European Union or EU.

TUKYSA is an oral, small molecule tyrosine kinase inhibitor (TKI) of HER2, a protein that contributes to cancer cell growth.

The positive CHMP opinion is based on results of the pivotal trial HER2CLIMB and were published in the New England Journal of Medicine in December 2019.

TUKYSA is approved in the U.S., Canada, Switzerland, Singapore and Australia.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Fast-food giant McDonald's said it will be raising hourly wages for more than 36,500 hardworking employees at McDonald's-owned restaurants by an average of 10 percent to make it among the industry-leading pay and benefits package. These increases, which have already begun, will be rolled out over the next several months. Biogen Inc. (BIIB) Friday said its XIRIUS study of cotoretigene toliparvovec failed to meet its primary endpoint in Phase 2/3 in patients with X-linked retinitis pigmentosa or XLRP. The company further noted that the study obtained positive trends in other pre-specified clinically relevant endpoints,... General Mills Inc. (GIS) agreed to buy Tyson Foods' (TSN) pet treats business for $1.2 billion in cash, the companies said in a statement on Friday. The transaction includes the Nudges, Top Chews and True Chews brands. General Mills will also acquire a manufacturing facility in Independence, Iowa.
Follow RTT